Shares of Orchid Pharma on Friday hit a 52-week high of ₹435.45 apiece on NSE after the company reported a turnaround in its financial performance.
The Chennai-based company recorded a net profit of ₹55.24 crore for 2022-23 against a net loss of ₹56.89 crore for 2021-22. The company’s share on the NSE hit the 5 per cent upper circuit for a second day in row.
This is a Premium article available exclusively to our subscribers.
Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...
You have reached your free article limit. Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...
You have reached your free article limit. Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...
TheHindu Businessline operates by its editorial values to provide you quality journalism.